Subject of the day
VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $197.52M | +60.9% | |
| Gross profit | $172.11M | +133.9% | |
| Operating income | $11.04M | +365.6% | |
| Net income | -$3.18M | — | |
| Cash from ops | $58.16M | +34.9% |
$44.54
▼ -0.19 (-0.4%)
| 52w hi | $48.31 |
|---|---|
| 52w lo | $29.34 |
| Vol | 527.89K |
| As of | Aug 13 |
Our score +0.63
| Short | +0.56 |
|---|---|
| Medium | +0.81 |
| Long | +0.42 |
computed 2026-08-13
Vericel Corporation
Healthcare · Biotechnology
| Market cap | $2.28B |
|---|---|
| Enterprise value | $2.22B |
| Trailing P/E | 92.79x |
| Forward P/E | 52.65x |
| EV / EBITDA | 71.30x |
| P / S (ttm) | 7.45x |
| Profit margin | 7.9% |
| Return on equity | 7.2% |
| Revenue growth | +22.5% |
| Earnings growth | — |
| Debt / equity | 25.17 |
| Beta vs SPX | 1.15 |
|---|---|
| Corr SPX | 0.40 |
| Annual vol | 46.3% |
| Annual ret | +8.8% |
| Sharpe | 0.19 |
| Max DD | -52.5% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.17 | |
| Sector | +0.12 | |
| Technical | +0.48 | |
| Earnings | +0.00 | |
| Sentiment | -0.13 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $45.34 | $46.13 | $43.74 | $44.54 | 527.89K |
| Aug 12 | $44.11 | $44.90 | $43.66 | $44.73 | 290.80K |
| Aug 11 | $44.30 | $45.27 | $44.01 | $44.35 | 416.90K |
| Aug 10 | $44.48 | $44.82 | $43.15 | $43.95 | 415.80K |
| Aug 7 | $44.83 | $45.57 | $44.35 | $45.09 | 472.90K |